| abstract |
The present disclosure provides aromatic cationic peptide compositions and methods of use thereof. The method comprises treating, preventing, or ameliorating symptoms of an autoimmune disease or condition using peptides to inhibit electron transfer, cardiolipin peroxidation, and apoptosis and necrosis. [Selection] Figure 1 |